March 17th, 2004
Boston Cure Project
I hadn't noticed this before, but Biogen is partnering with Fumapharm AG in Germany to run trials testing their oral psoriasis drug FUMADERM for MS. Not a lot of details available, but something interesting to look out for. Hopefully they'll come out with an injectable version too (just kidding!).
Copyright © 2004, Boston Cure Project